Table 2.

EC50 data for isolates belonging to FIESC-15a and FIESC-16a.

Sample	MLST Type	Growth Inhibition (%) 1	EC50 (µg/mL)
3	15-a	52.94	9.1
13	15-a	49.02	10.4
15	15-a	54.90	7.8
20	15-a	60.61	5.5
22	15-a	52.38	9.5
28	15-a	43.48	13.3
31	15-a	55.56	7.7
33	15-a	62.86	4.7
36	15-a	52.94	9.1
2	16-a	48.39	10.1
5	16-a	42.42	13.8
6	16-a	56.41	7.2
14	16-a	58.82	6.3
18	16-a	39.39	10.8
21	16-a	64.29	4.3
25	16-a	64.29	4.3
26	16-a	58.82	6.4
27	16-a	62.86	4.7
29	16-a	31.58	18.4
32	16-a	35.00	17.1
35	16-a	48.39	10.9
38	16-a	42.42	13.8
39	16-a	56.41	7.7
40	16-a	52.94	8.7
41	16-a	49.02	10.5
42	16-a	50.98	11.5
47	16-a	39.39	10.8
49	16-a	45.45	5.5
50	16-a	53.85	12.4
51	16-a	49.02	10.5

¹ Growth inhibition was determined for 10 µg/mL of tebuconazole.